Noll CampbellPharmD, MS
Organization :Regenstrief Institute
Dr. Campbell’s research is focused on the relationship between medications and brain health among older adults with acute and chronic cognitive impairment. He is an expert in the identification and measurement of the adverse cognitive effects of medications. He also conducts research in the field of medication adherence among older adults with cognitive impairment.
As a clinician, Dr. Campbell maintains an active practice as a geriatric pharmacotherapy expert within Eskenazi Health in Indianapolis. In 2012 he was awarded a New Investigator Award from the American Geriatrics Society, and in 2014 he received a five-year K23 career development award from the National Institute on Aging to continue his work on the adverse cognitive effects of medications.